Literature DB >> 11713288

Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.

J Gu1, L Nie, D Wiederschain, Z M Yuan.   

Abstract

It has been demonstrated that MDM2 can differentially regulate subcellular distribution of p53 and its close structural homologue p73. In contrast to MDM2-mediated p53 nuclear export, p73 accumulates in the nucleus as aggregates that colocalize with MDM2. Distinct distribution patterns of p53 and p73 suggest the existence of unique structural elements in the two homologues that determine their MDM2-mediated relocalization in the cell. Using a series of p53/p73 chimeric proteins, we demonstrate that three regions of p53 are involved in the regulation of MDM2-mediated nuclear export. The DNA binding domain (DBD) is involved in the maintenance of a proper conformation that is required for functional activity of the nuclear export sequence (NES) of p53. The extreme C terminus of p53 harbors several lysine residues whose ubiquitination by MDM2 appears to be the initial event in p53 nuclear export, as evidenced by the impaired nucleocytoplasmic shuttling of p53 mutants bearing simultaneous substitutions of lysines 370, 372, 373, 381, 382, and 386 to arginines (6KR) or alanines (6KA). Finally, the region between the DBD and the oligomerization domain of p53, specifically lysine 305, also plays a critical role in fully revealing p53NES. We conclude that MDM2-mediated nuclear export of p53 depends on a series of ubiquitination-induced conformational changes in the p53 molecule that lead to the activation of p53NES. In addition, we demonstrate that the p53NES may be activated without necessarily disrupting the p53 tetramer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713288      PMCID: PMC100016          DOI: 10.1128/MCB.21.24.8533-8546.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  22 in total

Review 1.  Regulation and function of the p53-related proteins: same family, different rules.

Authors:  M A Lohrum; K H Vousden
Journal:  Trends Cell Biol       Date:  2000-05       Impact factor: 20.808

Review 2.  Regulation of p53 stability.

Authors:  M Ashcroft; K H Vousden
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

3.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Subcellular distribution of p53 and p73 are differentially regulated by MDM2.

Authors:  J Gu; L Nie; H Kawai; Z M Yuan
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

5.  The MDM2 RING-finger domain is required to promote p53 nuclear export.

Authors:  R K Geyer; Z K Yu; C G Maki
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

6.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.

Authors:  S D Boyd; K Y Tsai; T Jacks
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

7.  The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.

Authors:  M Argentini; N Barboule; B Wasylyk
Journal:  Oncogene       Date:  2001-03-15       Impact factor: 9.867

8.  Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.

Authors:  S Nakamura; J A Roth; T Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

9.  C-terminal ubiquitination of p53 contributes to nuclear export.

Authors:  M A Lohrum; D B Woods; R L Ludwig; E Bálint; K H Vousden
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

10.  The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal.

Authors:  S H Liang; M F Clarke
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

View more
  30 in total

1.  ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.

Authors:  Lionel Le Gallic; Laura Virgilio; Philip Cohen; Benoit Biteau; George Mavrothalassitis
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Critical role for a central part of Mdm2 in the ubiquitylation of p53.

Authors:  Erik Meulmeester; Ruth Frenk; Robert Stad; Petra de Graaf; Jean-Christophe Marine; Karen H Vousden; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

3.  Critical contribution of the MDM2 acidic domain to p53 ubiquitination.

Authors:  Hidehiko Kawai; Dmitri Wiederschain; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

4.  The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein.

Authors:  Michela Muscolini; Elisa Montagni; Vanessa Palermo; Silvia Di Agostino; Wei Gu; Salma Abdelmoula-Souissi; Cristina Mazzoni; Giovanni Blandino; Loretta Tuosto
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

5.  Ubiquitination and degradation of mutant p53.

Authors:  Natalia Lukashchuk; Karen H Vousden
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

6.  MSL2 promotes Mdm2-independent cytoplasmic localization of p53.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  J Biol Chem       Date:  2008-11-25       Impact factor: 5.157

7.  C-terminal ubiquitination of p53 contributes to nuclear export.

Authors:  M A Lohrum; D B Woods; R L Ludwig; E Bálint; K H Vousden
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

8.  p53 targets simian virus 40 large T antigen for acetylation by CBP.

Authors:  Danielle L Poulin; Andrew L Kung; James A DeCaprio
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 9.  ROS and p53: a versatile partnership.

Authors:  Bin Liu; Yumin Chen; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2008-01-26       Impact factor: 7.376

10.  Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL.

Authors:  Dmitri Wiederschain; Hidehiko Kawai; JiJie Gu; Ali Shilatifard; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.